BRK-B — Berkshire Hathaway Inc.
Berkshire Hathaway is the single most complete expression of the principle that an insurer with structural underwriting discipline can compound capital faster than almost any other business — not because insurance itself is exceptional, but because insurance float is permanent, costless capital that, deployed into operating businesses with durable advantages, compounds without structural limit. At $499 per B-share, the stock trades at roughly 17.7 times normalized pre-tax earnings and 1.50 times book value, modestly above the threshold where the current earning power justifies the price without any growth assumption. The specific catalyst that closes that gap is Greg Abel deploying $370 billion in Treasury bills into operating businesses at returns materially above the 3.6% those bills currently earn — the one decision that will define whether Berkshire's second chapter matches its first.
The succession question that dominated Berkshire Hathaway's shareholder discussions for a decade resolved quietly on January 1, 2026. Greg Abel, who had managed Berkshire's non-insurance operations for the previous twenty-six years, became chief executive. Warren Buffett remained as executive chairman. The transition produced no investor day, no strategic reset, no new capital allocation framework. What it produced, within forty-eight hours, was a $9.7 billion acquisition: OxyChem, the chemical subsidiary of Occidental Petroleum, purchased for approximately eight times EBITDA. New management. Same language.
The company Abel inherited contains multitudes. Its insurance operations — GEICO, General Re, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group — generated $176 billion in float as of year-end 2025. BNSF Railway runs across 32,500 route miles and moves roughly a fifth of all inter-city freight in the western United States. Berkshire Hathaway Energy owns regulated utilities and pipelines across ten states. Alongside these three anchor businesses sit roughly seventy wholly-owned operating companies in manufacturing, retail, and services, plus a $267 billion equity portfolio anchored by Apple, American Express, and Coca-Cola. And, as of year-end 2025: approximately $370 billion in cash and short-term Treasury bills. That figure is the single most important fact in the current investment case — both the primary source of Berkshire's opportunity and the primary explanation for why the stock sits just above its normalized earnings threshold.
The fundamental mechanism that makes Berkshire structurally different from a diversified industrial conglomerate is the insurance float. An insurer collects premiums before paying claims; the gap between collection and payment is capital the insurer controls but does not own. Most insurers pay for their float by underwriting at a loss, accepting combined ratios above 100% and relying on investment income to compensate. Berkshire's insurance operations have historically underwritten at a profit in most years, meaning the company has been paid to hold capital it can invest elsewhere. The $176 billion float comes at negative cost in profitable underwriting years. This is not leverage in the conventional sense: it does not mature, it cannot be called, and it has grown in every year since 1967. Float that grows for fifty-eight consecutive years is not temporary. It is as close to permanent costless capital as exists in any publicly traded company, and it is the reason Berkshire's long-term return on equity exceeds what its operating businesses alone would generate.
GEICO's recovery over the past three years is the operational story that most directly drove the improvement in Berkshire's insurance earnings from distress to historically strong levels. The auto insurer entered 2022 with pricing calibrated for pre-pandemic claim costs. That calibration proved wrong when used car values spiked, body repair labor rates jumped, and medical cost trends accelerated simultaneously. The combined ratio — claims and expenses as a percentage of premiums, where below 100% means profit — hit 104.8% in 2022. GEICO was losing money on underwriting while competing against Progressive, which had responded faster to the same cost environment and emerged with its discipline intact. The turnaround was aggressive: GEICO raised rates sharply, shed unprofitable policies by the millions, and rebuilt its pricing framework. The result has been one of the sharpest recoveries in the property-casualty insurance industry in recent memory.
| Insurer | 2022 Combined Ratio | 2023 Combined Ratio | 2024 Combined Ratio |
|---|---|---|---|
| GEICO | 104.8% | ~96% | 90.3% |
| Progressive | ~96% | ~93% | ~91% |
| Allstate | ~109% | ~103% | ~97% |
| State Farm | ~112% | ~109% | ~102% |
What the table shows is not merely recovery but a GEICO that has outrun its largest competitor in underwriting profitability over the past two years. By the third quarter of 2025, GEICO's combined ratio reached 84.3% — a level implying the company is being paid meaningfully to hold its policyholders' premiums. Progressive, which navigated the 2022 environment better than GEICO, has stabilized in the low 90s. GEICO has moved below it. This reflects pricing discipline combined with the structural advantage of GEICO's direct-to-consumer distribution: lower acquisition costs allow GEICO to price policies below competitors' fully loaded cost and still earn underwriting profit. The competitive position that looked endangered in 2022 is now demonstrably stronger than it was before the crisis.
BNSF and Berkshire Hathaway Energy are businesses whose competitive position is determined by geography and regulation rather than by product development or market share contests. BNSF generated $8.1 billion in operating cash flows in 2025 and returned $4.4 billion to Berkshire via dividends. The railroad's economic logic is simple: it runs through terrain that took over a century to develop and cannot be replicated at any price. For freight shippers in the western United States, BNSF competes primarily with Union Pacific, and the two together form a structural duopoly. Earnings are cyclically sensitive — 2025 volumes were modestly below 2024 — but the competitive position is a geographic fact, not a strategy that can be disrupted. BHE contributed $8.4 billion in operating cash flows from regulated utilities and pipelines, businesses whose allowed returns are set by state commissions and whose capital intensity creates the barrier to competition that makes regulated utilities defensible. The one genuine uncertainty in BHE's profile is PacifiCorp's exposure to western wildfire litigation: the liability remains unquantified and represents an open question that no outside analysis can resolve without access to internal claims modeling that Berkshire has not disclosed. It is a real risk, not a theoretical one.
The equity portfolio tells a revealing story about what Berkshire's management did not find compelling in public markets for the past three years. Net equity selling across twelve consecutive quarters through 2025 — including trimming Apple from $155 billion to approximately $75 billion and exiting Bank of America at prices above current levels — reflects a judgment that the aggregate valuation of public equities did not offer the margin of safety that Berkshire's historical returns required. The corollary of not finding anything worth buying is the $370 billion pile in Treasury bills earning 3.6%. This discipline is the same discipline that produced the long-run compounding record. It is also the reason the current stock price sits at a modest premium to its normalized earnings threshold: a company whose most valuable asset is earning 3.6% instead of 12% is, by definition, temporarily underearning relative to its capital base.
Abel's capital allocation record, now visible through his first major decision, supports the conclusion that the standard has not changed. OxyChem at eight times EBITDA — purchased from a company whose equity Berkshire already owned, providing informational advantages about business quality that external buyers lacked — is consistent with Berkshire's historical preference for industrial businesses with pricing power. PVC and chlor-alkali production is not glamorous, but OxyChem's vertical integration gives it cost advantages over pure-play competitors in segments where commodity pricing can be brutal. The $9.7 billion deployment is 2.6% of the cash pile. The rate at which Abel deploys the remainder is the variable that will matter most to Berkshire's earning power over the next five years.
Abel has committed to investing his entire after-tax salary in Berkshire stock, and he has continued to repurchase shares at prices near current levels. These actions are the most credible available signal about management's private estimate of intrinsic value: a chief executive who deploys personal capital at current prices is making a verifiable claim about the margin between price and value. Howard Buffett remains as non-executive chairman, providing governance continuity that institutional shareholders value for reasons that go beyond formality. The combination of a CEO with twenty-six years of institutional knowledge and personal financial commitment to the outcome, and a chairman whose family name is inseparable from the company's identity, is an unusual arrangement that functions as a credible trust signal in an era when capital allocation discipline is frequently promised and infrequently kept.
The operating earnings trajectory from 2021 through 2025 captures both the power of the model and the cyclical interruption that makes 2025 the wrong year to read as normalized earnings:
| Year | Operating Earnings ($B) | GEICO Combined Ratio | Float ($B) | Cash / T-Bills ($B) | Book Value / B-Share ($) |
|---|---|---|---|---|---|
| 2021 | $27.5 | 99.6% | $147 | $144 | $232 |
| 2022 | $28.7 | 104.8% | $164 | $109 | $241 |
| 2023 | $37.4 | ~96% | $169 | $168 | $272 |
| 2024 | $47.4 | 90.3% | $171 | $334 | $302 |
| 2025 | $44.5 | ~84–86% | $176 | $370 | $333 |
The $44.5 billion reported for 2025 represents operating earnings under conditions that included a catastrophic fourth quarter: Southern California wildfire losses hit Berkshire's property reinsurance operations severely enough to reduce Q4 operating earnings to approximately $10.2 billion, against a quarterly run-rate that had been tracking above $14 billion through the first three quarters. GEICO itself was not materially affected — the combined ratio continued improving through the period. Strip out the Q4 reinsurance shock and the underlying mid-cycle earnings run-rate is approximately $48 billion annually. The float has never declined in fifty-eight years. The cash grew from $334 billion to $370 billion in a single year, not because Berkshire generated that much free cash flow, but because Buffett found almost nothing worth buying at public market prices. Book value per B-share grew from $302 to $333, a 10.3% increase on retained operating earnings and portfolio appreciation.
The penetration argument for Berkshire is inverted relative to conventional growth businesses. The company has already captured the domestic insurance, railroad, and utility positions it will likely hold for decades. The opportunity is not in untapped customer markets but in the deployment of dormant capital: $370 billion earning 3.6% in Treasury bills against a business portfolio that historically has earned 10 to 15 percent on capital. Every billion dollars that moves from Treasury bills into an operating business at a 12% pre-tax return adds approximately $84 million in incremental annual earnings relative to the T-bill baseline — the difference between deploying and waiting. A $200 billion deployment at historical acquisition returns would add roughly $16.8 billion in annual operating earnings, a 38% increase over the current midcycle base. The question of what fraction of the $370 billion will be deployed, at what returns, and on what timeline, is the entire investment thesis compressed into a single variable.
At $499 per B-share and a market capitalization of approximately $1.08 trillion, Berkshire trades at 1.50 times book value, modestly above the company's ten-year median of roughly 1.41 times. Against mid-cycle normalized pre-tax operating earnings — derived from a $48 billion after-tax midcycle estimate divided by a 0.79 tax retention factor, yielding approximately $60.8 billion pre-tax, or $28.13 per B-share equivalent — the stock trades at approximately 17.7 times. The 15 times threshold that separates "fair price requiring no growth" from "growth must materialize" is breached by roughly 18%. The price at which that threshold would be met is approximately $422 per B-share — the level at which 15 times normalized pre-tax earnings equals the market price. Buyers today pay a premium above that level of roughly 18%.
The intrinsic value argument that Abel is implicitly making by repurchasing shares at these prices rests on the claim that the cash pile is not fairly valued at T-bill rates — that $370 billion under disciplined management earning historical acquisition returns is worth more than $370 billion in Treasury bills, and that the market is not crediting the full option value of deployment. This argument is mathematically coherent. If Abel deploys $200 billion at 12% pre-tax returns, the effective multiple paid by a buyer at $499 today falls from 17.7 times to approximately 13 times on the operating earnings that deployment would generate. That arithmetic is not guaranteed, but it is the work of a manager who has already demonstrated in his first forty-eight hours that he understands it precisely.
The intelligent bear argues that Berkshire has become too large to generate returns materially above T-bill rates — that the universe of businesses large enough to matter to Berkshire's earnings and available at rational prices has contracted to near zero, and that the $370 billion problem is structural rather than cyclical. To grow Berkshire's earnings by 10% requires deploying $50 billion at historical returns; there is no track record of deploying capital at that velocity while maintaining return discipline, and the OxyChem acquisition at $9.7 billion is evidence of prudence, not scale. This is serious. The answer is that OxyChem at eight times EBITDA — a disciplined price for a business with genuine pricing power — is not the behavior of a manager who has run out of ideas; it is the behavior of a manager who waited until he found something that met the standard, then moved immediately. The succession risk that the market spent years discounting has resolved into a CEO who has shown both the discipline and the willingness to act. The question is whether the targets at rational prices will be large enough and frequent enough to absorb the pile meaningfully.
Berkshire Hathaway at $499 is a collection of excellent businesses — GEICO at historically strong underwriting margins, BNSF with irreplaceable western freight geography, BHE with regulated earnings certainty, seventy private businesses generating substantial pre-tax cash flows, and $176 billion in costless float — purchased at a price that is modestly above what those businesses would justify without requiring the $370 billion to be put to work productively. The stock is interesting today; it is compelling the moment Abel converts a meaningful portion of that pile into operating earnings. The distance between those two descriptions is exactly the premium above $422 that a buyer at current prices is paying.
The cash is real, the float is permanent, and the management is aligned. The price is not quite right.
Was this analysis useful?